403: Day 15 Dendritic Cell Recovery Predicts Overall Survival after Autologous Stem Cell Transplantation in non-Hodgkin's lymphoma  by Siddiqui, M.A. et al.
146 Poster Session II402
PD-1 EXPRESSION IS LINKED TO CMV DISEASE AND PROLONGED CMV
INFECTION AFTER HCT
Gallez-Hawkins, G.M.1, Thao, L.1, Palmer, J.2, Li, X.1, Franck, A.E.1,
Lacey, S.F.3, Diamond, D.J.3, Forman, S.J.4, Zaia, J.A.1. 1Beckman Re-
search Institute of City of Hope, Duarte, CA; 2City of Hope, Duarte, CA;
3Beckman Research Institute of City of Hope, Duarte, CA; 4City of Hope,
Duarte, CA.
PD-1 expression has been linked to chronic viral infection in both
mice (Barber DL et al, Nature 2006, 7077: 682–7) and man (Traut-
mann L et al Nat Med.2006; 10:1198–202). Although PD-1 expres-
sion has not been shown to be up-regulated in CMV-specific CD81
T cells of HIV-infected subjects, recently the up-regulation of PD-
1 has been associated with CMV disease after liver transplantation
(LaRosa et al. J. Infect Dis in press 2007). The question of whether
PD-1 expression influences the course of CMV infection after HCT
is unknown. We hypothesized that if PD-1 expression is associated
with risk for prolonged infection or disease, then it would be up-
regulated on CD41 and CD81T cells of HCT recipients with
CMV infection and disease.
Method: Subjects were followed prospectively for CMV-specific
immune reconstitution after HCT. Subsets of these subjects were
selected based on demonstration of prolonged CMV infection,
defined as .10 positive CMV qPCR assays in the first 100 days
post-HCT (n 5 14), development of CMV disease (n 5 14), or
a non-CMV viremic group (n 5 25). These were tested for
CD41 and CD81/PD11 expression by FACS analysis. The MFI
(mean fluorescence intensity) of PD-1 expression was reported for
unstimulated, pp65-peptide mixture and HIV-peptide mixture
[Pepmix] (negative control) stimulated cells, at days 90, 120, 180,
and 360 post transplant, and analyzed statistically using the non-
parametric Mann-Whitney test (www.graphpad.com). Results:
The PD-1 expression (MFI) was significantly higher in CD41
(p\ 0.004) and CD81 (p\ .009) lymphocytes at days 90, 120,
and 180 post-HCT in the CMV disease group than the non-viremic
group. For the group with prolonged viremia, the PD-1 expression
was significantly higher only for the CD81 cells (p\0.05) at these
same times. However, the total number of PD-1 positive cells was
not different between these groups. At day 360 post-transplant,
the PD1 MFI values did not differ between groups. When CD4
or CD8 cells were stimulated in vitro at these observation points, us-
ing either pp65 Pepmix or control HIV Pepmix, a similar significant
difference between CMV disease group and non-viremic group was
observed (p\0.007 for both CD41 and CD81 cells).Conclusion:
CMV disease and prolonged viremia in HCT subjects is associated
with higher expression of PD-1 and could manifest T cell exhaus-
tion, detectible by day 90 post-HCT. This could be an important
risk factor in development of subsequent CMV disease in HCT
recipients.403
DAY 15 DENDRITIC CELL RECOVERY PREDICTS OVERALL SURVIVAL AF-
TER AUTOLOGOUS STEM CELL TRANSPLANTATION IN NON-HODGKIN’S
LYMPHOMA
Siddiqui, M.A., Markovic, S.N., Nevala, W.K., Morice, W.,
Inwards, D.J., Ansell, S.M., Micallef, I.N., Johnston, P.B., Porrata, L.
Mayo Clinic, Rochester, MN.
The peripheral blood absolute lymphocyte count (ALC) on day
15 after autologous stem cell transplantation (ASCT) has been
shown to be an independent predictor for overall survival (OS) for
many malignancies including acute myelogenous leukemia
(AML), breast cancer, multiple myeloma (MM), primary systemic
amyloidosis, and Hodgkin’s and non-Hodgkin’s lymphoma
(NHL). A recent report (Dean et al. BMT 2005; 36, 1049–1052)
suggested that infused autograft dendritic cells (DC) affect survival
post-ASCT in NHL. Thus, DC recovery at day 15 post-ASCT was
assessed and correlated with OS. Preliminary data from an ongoing
prospective study of 28 NHL patients post-ASCT are reported. Ab-
solute DC at day 15 was analyzed by four color flow cytometry using
antibodies to CD3, CD14, CD16, and CD19. In this approach lym-phocytes and DCs were initially gated by their similar forward and
side light scatter characteristics; DCs were then identified as cells in
this gate that lacked staining for the lymphocyte antigens CD3,
CD16, and CD19 and the monocyte antigen CD14. The percent-
age of antigen negative cells cells in the lymphocyte gate was then
multiplied by the coincident peripheral blood absolute lymphocyte
to determine the absolute DC count. Survival was then analyzed us-
ing the Kaplan-Meier method. With a median follow-up of 18
months, patients recovering a DC of 10 cells/ml or above experi-
enced superior median OS versus those who did not (not reached
vs 21 months, p\0.02). This study shows that an immunocompe-
tent immune system at day 15 (not only ALC recovery, but also DC
recovery) correlates with survival in NHL patients undergoing
ASCT. This study was supported in part by the Grant CA90628–
04A from the National Institute of Health, and the University of
Iowa/Mayo Clinic Lymphoma Spore CA97274.404
RECONSTITUTION OF TCR REPERTOIRE DIVERSITY VIA HOMEOSTATIC
PROLIFERATION AFTER BONE MARROW TRANSPLANTATION
Zilberberg, J., Friedman, T.M., Korngold, R. Hackensack University
Medical Center, Hackensack, NJ.
The ability to mount protective immune responses depends upon
the existence of a diverse T cell repertoire. After age-related thymic
involution, the pool of naive and memory T cells is maintained con-
stant by a variety of thymus-independent homeostatic and cytokine-
driven proliferation mechanisms. Patients undergoing autologous
or allogeneic blood and marrow transplantation (BMT) often expe-
rience difficulties regaining a diverse TCR repertoire. Under these
lymphopenic conditions, homeostatic proliferation of mature do-
nor T cells from the stem cell innoculum greatly contributes to T
cell repertoire reconstitution. In examining reconstitution of the
CD8 and CD4 subsets following BMT, it is well known that the
numbers of CD41 T cells lag far behind the numbers of CD81,
and while many studies have focused on the factors contributing
to proliferation of donor T cells after BMT, the relationship be-
tween transplanted T cell numbers and reconstitution of a diverse
TCR repertoire has yet to be determined. To examine this relation-
ship we utilized a syngeneic transplant model, in which lethally ir-
radiated C57BL/6 (B6) mice received limited numbers (1  105
and 5  105) of B6eGFP1 T cells along with B6 T cell-depleted
bone marrow cells for hematopoietic reconstitution. At 15 and 60
days post-BMT, homeostatically proliferating eGFP1 T cells, har-
vested from the spleen and lymph nodes of recipient mice, were se-
lected by fluorescence activated cell sorting, and TCR Vb CDR3-
size spectratype analysis was used to examine repertoire complexity
of the CD41 and CD81 T cell populations. This analysis revealed
that as early as 15 days post-BMT, the CD81 subset exhibited 85%
overall complexity, whereas only 55% of the CD41 subset was com-
plex at day 60. This study will provide a better understanding of the
minimal cellular requirements for obtaining a complex repertoire,
which is especially critical for improving the clinical outcome of
transplanted individuals with diminished thymic activity.405
FATE OF THE CD41FOXP31 SUBSET WITHIN THE TOTAL CD41 T CELL
POPULATION FOLLOWING BMT
Zilberberg, J., Friedman, T.M., Korngold, R. Hackensack University
Medical Center, Hackensack, NJ.
Using murine bone marrow transplant model systems, it has been
demonstrated that the administration of exogenous regulatory T
cells (Treg), either at the time of transplant or several days later
as a delayed lymphocyte infusion, can effectively ameliorate the del-
eterious effects of graft-versus-host disease (GVHD) while preserv-
ing graft-versus-leukemia effects. Similarly, the question arises as to
whether homeostatic proliferation of donor-derived Treg could
